Drug

Ganfeborole clinical trials

Also written GSK3036656.

studies test it: 3
open now: 3
in phase 3: 0
first study started: 2023

Keep track of what changes. Save the ganfeborole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Ganfeborole: 2

Development codes

GSK3036656: 2

Studies by the year they started

3 studies that test it; most in 2023 (1)

Studies that test ganfeborole, by start year
Year	Studies
2023	1
2024	1
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 2

What it is tested for

Each study’s main condition, where its own words name it.

Tuberculosis, Pulmonary: 2
Tuberculosis: 1

Who runs them

Industry 1 · Other 2

University College, London (1) · GlaxoSmithKline (1) · Michael Hoelscher (1)

Often tested with

Tested in the same studies.

BTZ-043 (2) · Pretomanid (2) · Moxifloxacin (2) · Pyrazinamide (2) · Delpazolid (2) · Bedaquiline (1) · OPC-67683 (1) · Linezolid (1)

Studies

Open first, then newest update. How each study uses ganfeborole is read from its arms, and is right about nine times in ten.

Testing it · 3

Given in every arm · 1 — ganfeborole is usual care beside what is tested

Study of Combinations of Novel Promising Drugs for Pulmonary TuberculosisNot yet recruitingPhase 2TASK Applied ScienceNCT07773610Written as Ganfeborole 20 mg

Codes

What other systems call ganfeborole · ClinicalTrials.gg INT017113

UNII (FDA) KZ8H57WFC7GANFEBOROLEOne source FDA
NCI Thesaurus C199057GanfeboroleOne source FDA

System	Code	Name there	Checked by
UNII (FDA)	KZ8H57WFC7	GANFEBOROLE	One source FDA
NCI Thesaurus	C199057	Ganfeborole	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.